Discontinued — last reported Q3 '24
West Pharmaceutical Services Incentive stock program, shares reserved for future grants (in shares) decreased by 6.7% to $2.80M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 154.5%, from $1.10M to $2.80M.
A large reserve indicates potential for future dilution, while a small reserve may signal a need for future shareholder approval to authorize more shares.
This represents the total number of shares authorized for future issuance under the company's equity incentive plans. It...
Commonly disclosed by all public companies; peers vary based on the size of their workforce and the intensity of their equity-based compensation programs.
other_share_based_compensation_arrangement_by_share_base_608178| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $2.48M | $2.49M | $1.73M | $1.70M | $1.69M | $1.44M | $1.44M | $1.44M | $1.36M | $1.34M | $1.34M | $1.10M | $3.10M | $3.00M | $2.80M |
| QoQ Change | — | +0.0% | -30.5% | -1.5% | -0.5% | -14.7% | -0.5% | +0.1% | -5.6% | -1.3% | -0.1% | -17.8% | +181.8% | -3.2% | -6.7% |
| YoY Change | — | — | — | -31.5% | -31.9% | -16.4% | -15.5% | -15.0% | -6.0% | -6.8% | -6.9% | -19.0% | +131.4% | +124.1% | +154.5% |